Givlaari Injection, Solution
Product Images NDC 71336-1001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Givlaari (NDC 71336-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alnylam Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Givosiran 01)

Chemical structure diagram of givosiran sodium showing its double-stranded RNA oligonucleotide with labeled sense and antisense strands, including phosphodiester and phosphorothioate linkages. The structure highlights Watson-Crick base pairing and identifies L96, a conjugated chemical moiety, with detailed molecular formula.*

FDA Label Image

Principal Display Panel (189 mg/ml Vial Carton)

Packaging label for GIVLAARI (givosiran) injection, 189 mg/mL, a subcutaneous injection. The label shows it is a prescription-only drug by Alnylam Pharmaceuticals, Inc., manufactured by Ajinomoto Althea, Inc. It is presented as a single-dose vial for healthcare professional use. Storage instructions and dosage information references are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.